guanabenz has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, ST; Lasseter, KC; Pascucci, VL; Shapse, D | 1 |
| Argentieri, M; Mazzanti, A | 1 |
| Leenen, FH; Zhang, J | 1 |
3 other study(ies) available for guanabenz and Chronic Disease
| Article | Year |
|---|---|
Pharmacokinetics of guanabenz in patients with impaired liver function.
Topics: Adult; Blood Pressure; Chronic Disease; Female; Guanabenz; Guanidines; Humans; Kinetics; Liver Diseases; Male; Middle Aged | 1984 |
[Efficacy and tolerance of guanabenz in patients with associated chronic cardio-circulatory, respiratory, infectious and metabolic diseases].
Topics: Aged; Angina Pectoris; Arterial Occlusive Diseases; Arthritis; Bronchopneumonia; Chronic Disease; Diabetes Complications; Drug Tolerance; Female; Guanabenz; Guanidines; Heart Failure; Humans; Hypertension; Male; Middle Aged; Urinary Tract Infections | 1984 |
AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline.
Topics: Air Movements; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Chronic Disease; Guanabenz; Heart Rate; Hypertension; Injections, Intraventricular; Losartan; Male; Ouabain; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Saline Solution, Hypertonic; Stress, Physiological; Sympathetic Nervous System; Vasoconstrictor Agents | 2001 |